Cadent Therapeutics is a private, clinical stage biotech company that developed novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. Cadent’s pipeline included positive allosteric modulators to treat spinocerebellar ataxia, essential tremor and schizophrenia and MIJ821, treatment for resistant depression